Intramedullary Spinal Cord Ependymoma and Astrocytoma: Intraoperative Frozen-Section Diagnosis, Extent of Resection, and Outcomes

Total Page:16

File Type:pdf, Size:1020Kb

Intramedullary Spinal Cord Ependymoma and Astrocytoma: Intraoperative Frozen-Section Diagnosis, Extent of Resection, and Outcomes CLINICAL ARTICLE J Neurosurg Spine 30:133–139, 2019 Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes *Hiroki Hongo, MD,1 Keisuke Takai, MD, PhD,1 Takashi Komori, MD, PhD,2 and Makoto Taniguchi, MD, PhD1 Departments of 1Neurosurgery and 2Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo, Japan OBJECTIVE The intraoperative differentiation of ependymomas from astrocytomas is important because neurosurgical strategies differ between these two tumor groups. Previous studies have reported that the diagnostic accuracy of intra- operative frozen sections of intracranial central nervous system (CNS) tumors is higher than 83%–97%, whereas that for spinal intramedullary tumors remains unknown. Herein, authors tested the hypothesis that intraoperative frozen-section diagnosis is the gold standard for a differential diagnosis of intramedullary spinal cord tumors. METHODS The clinical characteristics, intraoperative histological diagnosis from frozen sections, extent of tumor resec- tion, progression-free survival (PFS), and overall survival (OS) of 49 cases of intramedullary spinal cord ependymomas (n = 32) and astrocytomas (n = 17) were retrospectively evaluated. RESULTS The frozen-section diagnosis and final diagnosis with permanent sections agreed in 23 (72%) of 32 cases of ependymoma. Of the 9 cases of ependymoma in which the frozen-section diagnosis disagreed with the final diagnosis, 4 were incorrectly diagnosed as astrocytoma and the other 5 cases had a nonspecific diagnosis, such as glioma. None- theless, gross-total resection was achieved in 6 of these 9 cases given the presence of a dissection plane. The frozen- section diagnosis and final diagnosis agreed in 12 (71%) of 17 cases of astrocytoma. Of the 5 cases of astrocytoma in which the frozen-section diagnosis disagreed with the final diagnosis, 1 was incorrectly diagnosed as ependymoma and the other 4 had a nonspecific diagnosis. Gross-total resection was achieved in only 1 of these 5 cases. A relationship between the size of tumor specimens and the diagnostic accuracy of frozen sections was not observed. Ependymal rosettes and perivascular pseudorosettes were observed in 30% and 57% of ependymomas, respectively, but were absent in astrocytomas. Progression-free survival and OS were both significantly longer in cases of ependymoma than in cases of astrocytoma (p < 0.001). Gross-total resection was achieved in 69% of ependymomas and was associated with longer PFS (p = 0.041). In the astrocytoma group, gross-total resection was achieved in only 12% and there was no relationship between extent of resection and OS. Tumor grades tended to correlate with OS in astrocytomas (p = 0.079). CONCLUSIONS The diagnostic accuracy of intraoperative frozen sections was lower for intramedullary spinal cord ependymomas and astrocytomas in the present study than that for intracranial CNS tumors reported on in the literature. Surgical strategies need to be selected based on multiple factors, such as clinical characteristics, preoperative imaging, frozen-section diagnosis, and intraoperative findings of the tumor plane. https://thejns.org/doi/abs/10.3171/2018.7.SPINE18230 KEYWORDS intramedullary tumor; progression-free survival; overall survival; histopathology; tumor grade; surgical treatment; radiation; chemotherapy; oncology ABBREVIATIONS CNS = central nervous system; GTR = gross-total resection; ISCT = intramedullary spinal cord tumor; OS = overall survival; PFS = progression-free survival; PR = partial resection; STR = subtotal resection. SUBMITTED February 28, 2018. ACCEPTED July 10, 2018. INCLUDE WHEN CITING Published online October 19, 2018; DOI: 10.3171/2018.7.SPINE18230. * H.H. and K.T. contributed equally to this study and share first authorship. ©AANS 2019, except where prohibited by US copyright law J Neurosurg Spine Volume 30 • January 2019 133 Unauthenticated | Downloaded 09/30/21 04:23 PM UTC Hongo et al. NTRAMEDULLARY spinal cord tumors (ISCTs) are rela- TABLE 1. Subtype classification of ependymomas and tively rare neoplasms that account for only 2%–4% of astrocytomas central nervous system (CNS) glial tumors. In adults, WHO Ependymomas Astrocytomas Iependymomas are the most common ISCT, comprising Grade Type No. Type No. approximately 50%–60% of ISCTs.2,3 Most ependymo- mas are slow growing and well demarcated from the spi- I Subependymoma 3 Pilocytic astrocytoma 2 nal cord parenchyma.7 Accordingly, gross-total resection II Ependymoma 28 Diffuse astrocytoma 9 (GTR) is possible in most cases of ependymoma. Previ- III Anaplastic ependymoma 1 Anaplastic astrocytoma 5 ous studies have reported that the extent of resection is IV Not applicable 0 Glioblastoma 1 a strong predictor of progression-free survival (PFS).2,8,9 Intramedullary astrocytomas, the second most common ISCT, possess more infiltrative features than ependymo- mas.7,14 Because of this infiltrative characteristic, the re- lationship between GTR and PFS in astrocytoma is less istic features on MRI.6 Patient demographics, symptoms, clear,12 and adjuvant therapy such as radiotherapy and preoperative McCormick grades,11 symptom duration pri- chemotherapy is often combined with resection.1,14 Since or to diagnosis, tumor location, tumor size, extent of resec- neurosurgical strategies differ between these two tumor tion, adjuvant therapy, follow-up period, recurrence/pro- groups, the differentiation of ependymoma from astrocy- gression, and death were collected from medical charts. toma is important. Tumor size was indicated by the number of vertebral bod- One method employed to differentiate the two tumor ies the tumor involved. Extent of excision was assessed on types is an intraoperative frozen-section diagnosis.13,15 initial postoperative MRI and defined as follows: GTR, Previous studies have reported that the diagnostic accu- no residual tumor; subtotal resection (STR), 90%–99% racy of intraoperative frozen sections of intracranial CNS resection; partial resection (PR), 5%–89% resection; and tumors is higher than 83%–97%,3,4,13,15,16 whereas that for biopsy, < 5% resection. Recurrence and progression were ISCTs remains unclear. In the present study, we aimed to defined as an increased tumor size on follow-up MRI. The test the hypothesis that intraoperative frozen-section di- median follow-up period was 70 months (range 1–252 agnosis is the gold standard for a differential diagnosis of months). ISCTs. Surgical cases of intramedullary spinal cord ep- endymomas and astrocytomas were reviewed in order to Frozen-Section Diagnosis clarify how the results of a frozen-section diagnosis affect Diagnostic reports of a frozen-section diagnosis were microsurgical treatments and outcomes. classified into 1) agree, agreement between frozen-section and final diagnoses regardless of tumor grade; 2) disagree, Methods no agreement between frozen-section and final diagnoses; and 3) nonspecific diagnosis, frozen-section diagnosis is Patient Population and Clinical Data too wide to be classified, i.e., glial tumors. Sensitivities, The present study was approved by the institutional re- specificities, and positive and negative predictive values view board at the Tokyo Metropolitan Neurological Hospi- were calculated for the differentiation of ependymomas tal. All patients gave full written informed consent for fro- from astrocytomas. zen- and permanent-section diagnoses. Regarding study In 36 cases (23 ependymomas and 13 astrocytomas), participation, written informed consent was not obtained the presence of ependymal rosettes and perivascular pseu- because this was a retrospective study. A public notice that dorosettes and the largest diameter of each specimen were provided information on this study was instead provided re-reviewed using the surgical specimens for frozen sec- by the Tokyo Metropolitan Neurological Hospital. tions. The relationship between the accuracy of the frozen- We retrospectively reviewed the medical records of 49 section diagnosis and the maximum diameter of frozen consecutive patients with intramedullary spinal cord ep- sections was examined. In the remaining 13 cases, surgi- endymomas (n = 32) and astrocytomas (n = 17) for whom cal specimens for frozen sections were not available. intraoperative frozen-section diagnoses were made at To- At our hospital, the chief of the neuropathological de- kyo Metropolitan Neurological Hospital between January partment changed three times over a 23-year study period; 1993 and March 2016. Formalin-fixed paraffin-embedded therefore, three experienced neuropathologists engaged sections were diagnosed based on the 2007 WHO classi- in the pathological diagnosis of spinal intramedullary tu- fication of CNS tumors (Table 1). Ependymomas included mors. One of the three neuropathologists, a single neuro- WHO grade I subependymoma, grade II ependymoma, pathologist, examined each frozen and permanent section. and grade III anaplastic ependymoma. Astrocytomas in- The relationship between the accuracy of the frozen-sec- cluded WHO grade I pilocytic astrocytoma, grade II dif- tion diagnosis and each pathologist was examined. fuse astrocytoma, grade III anaplastic astrocytoma, and grade IV glioblastoma. One recent case of diffuse midline Preoperative MRI Diagnosis glioma H3 K27M-mutant (WHO 2016)10 was classified as Diagnostic reports on the MRI were retrospectively anaplastic astrocytoma in the statistical analysis. Cases reviewed in cases for which the frozen-section
Recommended publications
  • Neurofibromatosis Type 2 (NF2)
    International Journal of Molecular Sciences Review Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis Suha Bachir 1,† , Sanjit Shah 2,† , Scott Shapiro 3,†, Abigail Koehler 4, Abdelkader Mahammedi 5 , Ravi N. Samy 3, Mario Zuccarello 2, Elizabeth Schorry 1 and Soma Sengupta 4,* 1 Department of Genetics, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA; [email protected] (S.B.); [email protected] (E.S.) 2 Department of Neurosurgery, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (M.Z.) 3 Department of Otolaryngology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (R.N.S.) 4 Department of Neurology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] 5 Department of Radiology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vestibular schwannomas. Meningiomas are a common primary brain tumor; many NF2 patients suffer from multiple meningiomas. In NF2, patients have mutations in the NF2 gene, specifically with loss of function in a tumor-suppressor protein that has a number of synonymous names, including: Merlin, Neurofibromin 2, and schwannomin. Merlin is a 70 kDa protein that has 10 different isoforms. The Hippo Tumor Suppressor pathway is regulated upstream by Merlin. This pathway is critical in regulating cell proliferation and apoptosis, characteristics that are important for tumor progression.
    [Show full text]
  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)
    Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma,
    [Show full text]
  • A Case of Intramedullary Spinal Cord Astrocytoma Associated with Neurofibromatosis Type 1
    KISEP J Korean Neurosurg Soc 36 : 69-71, 2004 Case Report A Case of Intramedullary Spinal Cord Astrocytoma Associated with Neurofibromatosis Type 1 Jae Taek Hong, M.D.,1 Sang Won Lee, M.D.,1 Byung Chul Son, M.D.,1 Moon Chan Kim, M.D.2 Department of Neurosurgery,1 St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea Department of Neurosurgery,2 Kangnam St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea The authors report a symptomatic intramedullary spinal cord astrocytoma in the thoracolumbar area associated with neurofibromatosis type 1 (NF-1). A 38-year-old woman presented with paraparesis. Magnetic resonance imaging revealed an intramedullary lesion within the lower thoracic spinal cord and conus medullaris, which was removed surgically. Pathological investigation showed anaplastic astrocytoma. This case confirms that the diagnosis criteria set by the National Institute of Health Consensus Development Conference can be useful to differentiate ependymoma from astrocytoma when making a preoperative diagnosis of intramedullary spinal cord tumor in patients of NF-1. KEY WORDS : Astrocytoma·Intramedullary cord tumor·Neurofibromatosis. Introduction eurofibromatosis type 1 (NF-1), also known as von N Recklinghausen's disease, is one of the most common autosomal dominant inherited disorders with an incidence of 1 in 3,000 individuals and is characterized by a predisposition to tumors of the nervous system5,6,12,16). Central nervous system lesions associated with NF-1 include optic nerve glioma and low-grade gliomas of the hypothalamus, cerebellum and brain stem6,10). Since the introduction of magnetic resonance(MR) imaging, Fig. 1. Photograph of the patient's back shows multiple subcutaneous incidental lesions with uncertain pathological characteristic nodules (black arrow) and a cafe-au-lait spot (white arrow), which have been a frequent finding in the brain and spinal cord of are typical of NF-1.
    [Show full text]
  • Risk-Adapted Therapy for Young Children with Embryonal Brain Tumors, High-Grade Glioma, Choroid Plexus Carcinoma Or Ependymoma (Sjyc07)
    SJCRH SJYC07 CTG# - NCT00602667 Initial version, dated: 7/25/2007, Resubmitted to CPSRMC 9/24/2007 and 10/6/2007 (IRB Approved: 11/09/2007) Activation Date: 11/27/2007 Amendment 1.0 dated January 23, 2008, submitted to CPSRMC: January 23, 2008, IRB Approval: March 10, 2008 Amendment 2.0 dated April 16, 2008, submitted to CPSRMC: April 16, 2008, (IRB Approval: May 13, 2008) Revision 2.1 dated April 29, 2009 (IRB Approved: April 30, 2009 ) Amendment 3.0 dated June 22, 2009, submitted to CPSRMC: June 22, 2009 (IRB Approved: July 14, 2009) Activated: August 11, 2009 Amendment 4.0 dated March 01, 2010 (IRB Approved: April 20, 2010) Activated: May 3, 2010 Amendment 5.0 dated July 19, 2010 (IRB Approved: Sept 17, 2010) Activated: September 24, 2010 Amendment 6.0 dated August 27, 2012 (IRB approved: September 24, 2012) Activated: October 18, 2012 Amendment 7.0 dated February 22, 2013 (IRB approved: March 13, 2013) Activated: April 4, 2013 Amendment 8.0 dated March 20, 2014. Resubmitted to IRB May 20, 2014 (IRB approved: May 22, 2014) Activated: May 30, 2014 Amendment 9.0 dated August 26, 2014. (IRB approved: October 14, 2014) Activated: November 4, 2014 Un-numbered revision dated March 22, 2018. (IRB approved: March 27, 2018) Un-numbered revision dated October 22, 2018 (IRB approved: 10-24-2018) RISK-ADAPTED THERAPY FOR YOUNG CHILDREN WITH EMBRYONAL BRAIN TUMORS, HIGH-GRADE GLIOMA, CHOROID PLEXUS CARCINOMA OR EPENDYMOMA (SJYC07) Principal Investigator Amar Gajjar, M.D. Division of Neuro-Oncology Department of Oncology Section Coordinators David Ellison, M.D., Ph.D.
    [Show full text]
  • Epidemiology and Survival of Patients with Brainstem Gliomas: a Population-Based Study Using the SEER Database
    ORIGINAL RESEARCH published: 11 June 2021 doi: 10.3389/fonc.2021.692097 Epidemiology and Survival of Patients With Brainstem Gliomas: A Population-Based Study Using the SEER Database † † Huanbing Liu 1 , Xiaowei Qin 1 , Liyan Zhao 2, Gang Zhao 1* and Yubo Wang 1* 1 Department of Neurosurgery, First Hospital of Jilin University, Changchun, China, 2 Department of Clinical Laboratory, Second Hospital of Jilin University, Changchun, China Background: Brainstem glioma is a primary glial tumor that arises from the midbrain, Edited by: pons, and medulla. The objective of this study was to determine the population-based Yaohua Liu, epidemiology, incidence, and outcomes of brainstem gliomas. Shanghai First People’s Hospital, China Methods: The data pertaining to patients with brainstem gliomas diagnosed between Reviewed by: 2004 and 2016 were extracted from the SEER database. Descriptive analyses were Kristin Schroeder, conducted to evaluate the distribution and tumor-related characteristics of patients with Duke Cancer Institute, United States Gerardo Caruso, brainstem gliomas. The possible prognostic indicators were analyzed by Kaplan-Meier University Hospital of Policlinico G. curves and a Cox proportional hazards model. Martino, Italy *Correspondence: Results: The age-adjusted incidence rate was 0.311 cases per 100,000 person-years Gang Zhao between 2004 and 2016. A total of 3387 cases of brainstem gliomas were included in our [email protected] study. Most of the patients were white and diagnosed at 5-9 years of age. The most Yubo Wang [email protected] common diagnosis confirmed by histological review was ependymoma/anaplastic †These authors have contributed ependymoma. The median survival time was 24 months.
    [Show full text]
  • Malignant CNS Solid Tumor Rules
    Malignant CNS and Peripheral Nerves Equivalent Terms and Definitions C470-C479, C700, C701, C709, C710-C719, C720-C725, C728, C729, C751-C753 (Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140) Introduction Note 1: This section includes the following primary sites: Peripheral nerves C470-C479; cerebral meninges C700; spinal meninges C701; meninges NOS C709; brain C710-C719; spinal cord C720; cauda equina C721; olfactory nerve C722; optic nerve C723; acoustic nerve C724; cranial nerve NOS C725; overlapping lesion of brain and central nervous system C728; nervous system NOS C729; pituitary gland C751; craniopharyngeal duct C752; pineal gland C753. Note 2: Non-malignant intracranial and CNS tumors have a separate set of rules. Note 3: 2007 MPH Rules and 2018 Solid Tumor Rules are used based on date of diagnosis. • Tumors diagnosed 01/01/2007 through 12/31/2017: Use 2007 MPH Rules • Tumors diagnosed 01/01/2018 and later: Use 2018 Solid Tumor Rules • The original tumor diagnosed before 1/1/2018 and a subsequent tumor diagnosed 1/1/2018 or later in the same primary site: Use the 2018 Solid Tumor Rules. Note 4: There must be a histologic, cytologic, radiographic, or clinical diagnosis of a malignant neoplasm /3. Note 5: Tumors from a number of primary sites metastasize to the brain. Do not use these rules for tumors described as metastases; report metastatic tumors using the rules for that primary site. Note 6: Pilocytic astrocytoma/juvenile pilocytic astrocytoma is reportable in North America as a malignant neoplasm 9421/3. • See the Non-malignant CNS Rules when the primary site is optic nerve and the diagnosis is either optic glioma or pilocytic astrocytoma.
    [Show full text]
  • Meningioma ACKNOWLEDGEMENTS
    AMERICAN BRAIN TUMOR ASSOCIATION Meningioma ACKNOWLEDGEMENTS ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Meningioma Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit advocacy organization dedicated solely to brain tumor research. For nearly 45 years, the ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care. To learn more about the ABTA, visit www.abta.org. We gratefully acknowledge Santosh Kesari, MD, PhD, FANA, FAAN chair of department of translational neuro- oncology and neurotherapeutics, and Marlon Saria, MSN, RN, AOCNS®, FAAN clinical nurse specialist, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA; and Albert Lai, MD, PhD, assistant clinical professor, Adult Brain Tumors, UCLA Neuro-Oncology Program, for their review of this edition of this publication. This publication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. Inclusion in this publication is not a recommendation of any product, treatment, physician or hospital. COPYRIGHT © 2017 ABTA REPRODUCTION WITHOUT PRIOR WRITTEN PERMISSION IS PROHIBITED AMERICAN BRAIN TUMOR ASSOCIATION Meningioma INTRODUCTION Although meningiomas are considered a type of primary brain tumor, they do not grow from brain tissue itself, but instead arise from the meninges, three thin layers of tissue covering the brain and spinal cord.
    [Show full text]
  • Circular RNA Expression Profiles in Pediatric Ependymomas Ulvi Ahmadov1, Meile M
    medRxiv preprint doi: https://doi.org/10.1101/2020.08.04.20167312; this version posted August 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Circular RNA expression profiles in pediatric ependymomas Ulvi Ahmadov1, Meile M. Bendikas2, Karoline K. Ebbesen2,3, Astrid M. Sehested4, Jørgen Kjems2,3, Helle Broholm5 and Lasse S. Kristensen1# 1. Department of Biomedicine, Aarhus University, Aarhus, Denmark 2. Molecular Biology and Genetics (MBG), Aarhus University, Aarhus, Denmark 3. Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark 4. Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Copenhagen, Denmark 5. Department of Pathology, Center of Diagnostic Investigation, Rigshospitalet, Copenhagen, Denmark # corresponding author Running title: CircRNAs expression profiles in pediatric ependymomas Correspondence should be addressed to: Lasse Sommer Kristensen, PhD, Department of Biomedicine, Høegh- Guldbergs Gade 10, building 1116, room 268, Aarhus University, 8000 Aarhus, Denmark. Phone: +45 28880562, E-mail: [email protected] Key words: Pediatric ependymoma, pilocytic astrocytoma, medulloblastoma, circular RNA, RNA-sequencing, NanoString nCounter 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.08.04.20167312; this version posted August 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • “Where Hope Springs Eternal”
    BASIC FACTS ABOUT EPENDYMOMA “Where hope springs eternal” Pediatric Brain Tumor Foundation of the United States A Resource for Families ACKNOWLEDGEMENTS The Pediatric Brain Tumor Foundation of the United States wishes to thank Ian Pollack, MD, Department of Neurosurgery, Children’s Hospital of Pittsburgh, Pittsburgh, PA, for the scientific review of this publication. SOURCES Statistical data in this publication was obtained from the Central Brain Tumor Registry of the United States (CBTRUS) and the World Health Organization Classification of Tumors, 2000. DISCLAIMER The Pediatric Brain Tumor Foundation of the United States does not engage in rendering medical advice or professional medical services. Information contained in this publication is NOT intended to be a substitute for medical care and should not be used for the diagnosing or the treatment of a brain tumor or any other health problem. If you have or even suspect you have a problem concerning your health or that of someone else, you should consult with your healthcare provider. The materials provided by the Pediatric Brain Tumor Foundation of the United States are compiled based on current information at the time that they were written. Medical research concerning disease and treatments is an ongoing process. We endeavor to keep our materials current. However, you should contact your doctors and medical institutions to seek the most current information available. COPYRIGHT Copyright© 2002 by the Pediatric Brain Tumor Foundation of the United States, Inc. The contents of this publication have been prepared for the exclusive use of the Pediatric Brain Tumor Foundation of the United States. It may not be reproduced in part or in its entirety without the written permission of the Pediatric Brain Tumor Foundation of the United States.
    [Show full text]
  • Long-Term Follow-Up of Coexisting Meningioma and Intramedullary Ependymoma As a Collision Tumor in the Spinal Cord: a Case Report
    Case Report Clinics in Surgery Published: 31 Jan, 2019 Long-Term Follow-Up of Coexisting Meningioma and Intramedullary Ependymoma as a Collision Tumor in the Spinal Cord: A Case Report Masatoshi Teraguchi1*, Mamoru Kawakami1, Shinichi Nakao2, Daisuke Fukui3 and Yukihiro Nakagawa1 1Spine Care Center, Wakayama Medical University, Japan 2Sumiya Orthopaedic Hospital, Wakayama, Japan 3Department of Orthopedic Surgery, Wakayama Medical University, Japan Abstract Background: Meningioma and ependymoma are usually presented as intramedullary and extramedullay tumor of spinal cord, respectively. However, coexistence of meningioma and ependymoma as a single mixed tumor in the single spinal cord and canal is an extremely rare occurrence. To our knowledge, there have been no reports on a mixed tumor with a distinct meningioma in thoracic region and ependymoma occurring at the cauda equina. Here, we report a case of long-term follow-up of coexisting meningioma and intramedullary ependymoma as a collision tumor in the spinal cord. Case Presentation: A 58-year-old woman presented with claudication in the lower limb one month after a fall from a step, characterized by weakness, numbness, and pain. MRI revealed two spinal lesions, one at the T4 level and the other in the cauda equina, at the L2 level, with L1 vertebral fracture. The patient underwent tumor resection via osteoplastic laminotomy from T3 to T5 and L2 to L3 simultaneously. Histopathological examination revealed that the tumor at the T4 level was a WHO grade I meningioma and that the lesion at L2 was a WHO grade II ependymoma. The postoperative course after 8 years was uneventful, with no recurrence, and the patient’s symptoms OPEN ACCESS resolved completely.
    [Show full text]
  • Sox10 Has a Broad Expression Pattern in Gliomas and Enhances Platelet-Derived Growth Factor-B–Induced Gliomagenesis
    Sox10 Has a Broad Expression Pattern in Gliomas and Enhances Platelet-Derived Growth Factor-B–Induced Gliomagenesis Maria Ferletta, Lene Uhrbom, Tommie Olofsson, Fredrik Ponte´n, and Bengt Westermark Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala, Sweden Abstract without any known intermediate stages of the tumor, whereas In a previously published insertional mutagenesis screen secondary glioblastoma arises by progression from a lower for candidate brain tumor genes in the mouse using a grade to a higher tumor grade. Common genetic alterations in Moloney mouse leukemia virus encodingplatelet-derived primary glioblastoma are amplification of EGFR and MDM2 growth factor (PDGF)-B, the Sox10 gene was tagged in and deletions of the INK4A gene (1, 2). During the progression five independent tumors. The proviral integrations of secondary glioblastoma, mutations accumulate over time suggest an enhancer effect on Sox10. All Moloney murine and more than 65% of the tumors have mutations in TRP53. leukemia virus/PDGFB tumors had a high protein Overexpression of the platelet-derived growth factor receptor-a expression of Sox10 independently of malignant grade (PDGFRA) and PDGFA are characteristic for secondary glio- or tumor type. To investigate the role of Sox10 in blastoma (3). Constitutive expression of growth factors and gliomagenesis, we used the RCAS/tv-a mouse model in their receptors has been shown to be necessary for the develop- which the expression of retroviral-encoded genes can be ment of brain tumors resulting in autocrine stimulation and directed to glial progenitor cells (Ntv-a mice). Both Ntv-a increased activity of downstream pathways (4). Inactivation transgenic mice, wild-type, and Ntv-a p19Arf null mice of the tumor suppressor gene phosphatase and tensin homo- were injected with RCAS-SOX10 alone or in combination logue (PTEN; refs.
    [Show full text]
  • Ependymoma with Intraorbital Extracerebral Recurrence: Case Report Ependimoma Com Recidiva Extracerebral Intraorbital: Relato De Caso
    Published online: 2019-09-03 THIEME 342 Case Report | Relato de Caso Ependymoma with Intraorbital Extracerebral Recurrence: Case Report Ependimoma com recidiva extracerebral intraorbital: relato de caso Lívio Pereira de Macêdo1 Benjamim Pessoa Vale2,3 Marx Lima de Barros Araújo2,3,4 João Cícero Lima Vale5 Yally Dayanne Oliveira Ferreira6 Suelen Maria Silva de Araújo7 1 Hospital da Restauração, Recife, PE, Brazil Address for correspondence Lívio Pereira de Macêdo, MD, 2 Instituto de Neurociências do Piauí, Teresina, PI, Brazil Departament of Neurosurgery, Hospital da Restauração, Recife, PE, 3 Hospital São Marcos, Teresina, PI, Brazil Brasil, 50050-200 (e-mail: [email protected]). 4 Hospital Universitário, Universidade Federal do Piauí, PI, Brazil 5 Faculdade Facid Wyden, Teresina, PI, Brazil 6 Centro Universitário Maurício de Nassau, Recife, PE, Brazil 7 Universidade Católica de Pernambuco, Recife, PE, Brazil Arq Bras Neurocir 2019;38:342–347. Abstract Ependymomas are rare neuroepithelial tumors that originate from a type of glial cell called ependymal cell. In general, they correspond to 1.2 to 7.8% of all intracranial neoplasms, and to 2 to 6% of all gliomas. Although it corresponds only to 2 to 3% of all primary brain tumors, ependymoma is the fourth most common cerebral neoplasm in children, especially in children younger than 3 years of age.1,2 In patients younger than 20 years of age, the majority (90%) of ependymomas are infratentorial, more precisely from the IV ventricle. In spite of this, in adults, medullary ependymomas are
    [Show full text]